Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Peptide Therapeutics can be widely used to treat cancer, metabolic disorders, and cardiovascular diseases. When the level of endogenous peptide tends to decline, peptide drugs will be used as an alternative therapy to supplement peptide hormones. Clinical global authorities in the United States, Europe and Japan have approved 60 peptide drugs.
During the forecast period, the Peptide Therapeutics market will achieve significant market growth, culminating in a compound annual growth rate of 8.4%. Cell-penetrating peptides will bring a broader prospect for the Peptide Therapeutics market. Cell-penetrating peptides, known as ideal transporters, assist therapeutic drugs in a nontoxic and simple manner, including proteins, oligonucleotides, nanoparticles, and so on.
The increase in the incidence rate of cancer and metabolic diseases such as osteoporosis, obesity and diabetes is a major factor driving the growth of Peptide Therapeutics market during the forecast period. In addition, the growing population base affected and the prevalence of targeted diseases in low-income countries will greatly stimulate the market demand for Peptide Therapeutics.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Peptide Therapeutics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Peptide Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Peptide Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novo Nordisk
Novartis
Shire
AstraZeneca
Roche
Teva
Eli Lilly
The Medicines
Ferring
Ipsen
Merck
Takeda
AbbVie
Allergan
Sanofi
J & J
By Type:
Injection
Oral
Other
By End-User:
Cancer
Metabolic Disorders
Central Nervous System
Cardiovascular Disorder
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Peptide Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Peptide Therapeutics Market Size and Growth Rate of Injection from 2016 to 2027
-
1.3.2 USA Peptide Therapeutics Market Size and Growth Rate of Oral from 2016 to 2027
-
1.3.3 USA Peptide Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Peptide Therapeutics Market Size and Growth Rate of Cancer from 2016 to 2027
-
1.4.2 USA Peptide Therapeutics Market Size and Growth Rate of Metabolic Disorders from 2016 to 2027
-
1.4.3 USA Peptide Therapeutics Market Size and Growth Rate of Central Nervous System from 2016 to 2027
-
1.4.4 USA Peptide Therapeutics Market Size and Growth Rate of Cardiovascular Disorder from 2016 to 2027
-
1.4.5 USA Peptide Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Peptide Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Peptide Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Peptide Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Peptide Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Peptide Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Peptide Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Injection
-
3.4.2 Market Size and Growth Rate of Oral
-
3.4.3 Market Size and Growth Rate of Other
4 Segmentation of Peptide Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Peptide Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Peptide Therapeutics in Cancer
-
4.4.2 Market Size and Growth Rate of Peptide Therapeutics in Metabolic Disorders
-
4.4.3 Market Size and Growth Rate of Peptide Therapeutics in Central Nervous System
-
4.4.4 Market Size and Growth Rate of Peptide Therapeutics in Cardiovascular Disorder
-
4.4.5 Market Size and Growth Rate of Peptide Therapeutics in Others
5 Market Analysis by Regions
-
5.1 USA Peptide Therapeutics Production Analysis by Regions
-
5.2 USA Peptide Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Peptide Therapeutics Landscape Analysis
-
6.1 West USA Peptide Therapeutics Landscape Analysis by Major Types
-
6.2 West USA Peptide Therapeutics Landscape Analysis by Major End-Users
7 South USA Peptide Therapeutics Landscape Analysis
-
7.1 South USA Peptide Therapeutics Landscape Analysis by Major Types
-
7.2 South USA Peptide Therapeutics Landscape Analysis by Major End-Users
8 Middle West USA Peptide Therapeutics Landscape Analysis
-
8.1 Middle West USA Peptide Therapeutics Landscape Analysis by Major Types
-
8.2 Middle West USA Peptide Therapeutics Landscape Analysis by Major End-Users
9 Northeast USA Peptide Therapeutics Landscape Analysis
-
9.1 Northeast USA Peptide Therapeutics Landscape Analysis by Major Types
-
9.2 Northeast USA Peptide Therapeutics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Novo Nordisk
-
10.1.1 Novo Nordisk Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Novartis
-
10.2.1 Novartis Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Shire
-
10.3.1 Shire Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 AstraZeneca
-
10.4.1 AstraZeneca Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Roche
-
10.5.1 Roche Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Teva
-
10.6.1 Teva Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Eli Lilly
-
10.7.1 Eli Lilly Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 The Medicines
-
10.8.1 The Medicines Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Ferring
-
10.9.1 Ferring Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Ipsen
-
10.10.1 Ipsen Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Merck
-
10.11.1 Merck Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Takeda
-
10.12.1 Takeda Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 AbbVie
-
10.13.1 AbbVie Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Allergan
-
10.14.1 Allergan Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 Sanofi
-
10.15.1 Sanofi Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 J & J
-
10.16.1 J & J Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Peptide Therapeutics Market Size and Growth Rate of Injection from 2016 to 2027
-
Figure USA Peptide Therapeutics Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure USA Peptide Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Peptide Therapeutics Market Size and Growth Rate of Cancer from 2016 to 2027
-
Figure USA Peptide Therapeutics Market Size and Growth Rate of Metabolic Disorders from 2016 to 2027
-
Figure USA Peptide Therapeutics Market Size and Growth Rate of Central Nervous System from 2016 to 2027
-
Figure USA Peptide Therapeutics Market Size and Growth Rate of Cardiovascular Disorder from 2016 to 2027
-
Figure USA Peptide Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Peptide Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Peptide Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Peptide Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Peptide Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Peptide Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Peptide Therapeutics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Peptide Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Peptide Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Injection
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Peptide Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Peptide Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Cancer
-
Figure Market Size and Growth Rate of Metabolic Disorders
-
Figure Market Size and Growth Rate of Central Nervous System
-
Figure Market Size and Growth Rate of Cardiovascular Disorder
-
Figure Market Size and Growth Rate of Others
-
Table USA Peptide Therapeutics Production by Regions
-
Table USA Peptide Therapeutics Production Share by Regions
-
Figure USA Peptide Therapeutics Production Share by Regions in 2016
-
Figure USA Peptide Therapeutics Production Share by Regions in 2021
-
Figure USA Peptide Therapeutics Production Share by Regions in 2027
-
Table USA Peptide Therapeutics Consumption by Regions
-
Table USA Peptide Therapeutics Consumption Share by Regions
-
Figure USA Peptide Therapeutics Consumption Share by Regions in 2016
-
Figure USA Peptide Therapeutics Consumption Share by Regions in 2021
-
Figure USA Peptide Therapeutics Consumption Share by Regions in 2027
-
Table West USA Peptide Therapeutics Consumption by Types from 2016 to 2027
-
Table West USA Peptide Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure West USA Peptide Therapeutics Consumption Share by Types in 2016
-
Figure West USA Peptide Therapeutics Consumption Share by Types in 2021
-
Figure West USA Peptide Therapeutics Consumption Share by Types in 2027
-
Table West USA Peptide Therapeutics Consumption by End-Users from 2016 to 2027
-
Table West USA Peptide Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Peptide Therapeutics Consumption Share by End-Users in 2016
-
Figure West USA Peptide Therapeutics Consumption Share by End-Users in 2021
-
Figure West USA Peptide Therapeutics Consumption Share by End-Users in 2027
-
Table South USA Peptide Therapeutics Consumption by Types from 2016 to 2027
-
Table South USA Peptide Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South USA Peptide Therapeutics Consumption Share by Types in 2016
-
Figure South USA Peptide Therapeutics Consumption Share by Types in 2021
-
Figure South USA Peptide Therapeutics Consumption Share by Types in 2027
-
Table South USA Peptide Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South USA Peptide Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Peptide Therapeutics Consumption Share by End-Users in 2016
-
Figure South USA Peptide Therapeutics Consumption Share by End-Users in 2021
-
Figure South USA Peptide Therapeutics Consumption Share by End-Users in 2027
-
Table Middle West USA Peptide Therapeutics Consumption by Types from 2016 to 2027
-
Table Middle West USA Peptide Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Peptide Therapeutics Consumption Share by Types in 2016
-
Figure Middle West USA Peptide Therapeutics Consumption Share by Types in 2021
-
Figure Middle West USA Peptide Therapeutics Consumption Share by Types in 2027
-
Table Middle West USA Peptide Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Peptide Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Peptide Therapeutics Consumption Share by End-Users in 2016
-
Figure Middle West USA Peptide Therapeutics Consumption Share by End-Users in 2021
-
Figure Middle West USA Peptide Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast USA Peptide Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast USA Peptide Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Peptide Therapeutics Consumption Share by Types in 2016
-
Figure Northeast USA Peptide Therapeutics Consumption Share by Types in 2021
-
Figure Northeast USA Peptide Therapeutics Consumption Share by Types in 2027
-
Table Northeast USA Peptide Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Peptide Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Peptide Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast USA Peptide Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast USA Peptide Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novo Nordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
-
Figure Sales and Growth Rate Analysis of Novo Nordisk
-
Figure Revenue and Market Share Analysis of Novo Nordisk
-
Table Product and Service Introduction of Novo Nordisk
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Shire
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire
-
Figure Sales and Growth Rate Analysis of Shire
-
Figure Revenue and Market Share Analysis of Shire
-
Table Product and Service Introduction of Shire
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of The Medicines
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of The Medicines
-
Figure Sales and Growth Rate Analysis of The Medicines
-
Figure Revenue and Market Share Analysis of The Medicines
-
Table Product and Service Introduction of The Medicines
-
Table Company Profile and Development Status of Ferring
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring
-
Figure Sales and Growth Rate Analysis of Ferring
-
Figure Revenue and Market Share Analysis of Ferring
-
Table Product and Service Introduction of Ferring
-
Table Company Profile and Development Status of Ipsen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ipsen
-
Figure Sales and Growth Rate Analysis of Ipsen
-
Figure Revenue and Market Share Analysis of Ipsen
-
Table Product and Service Introduction of Ipsen
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Takeda
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda
-
Figure Sales and Growth Rate Analysis of Takeda
-
Figure Revenue and Market Share Analysis of Takeda
-
Table Product and Service Introduction of Takeda
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of J & J
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of J & J
-
Figure Sales and Growth Rate Analysis of J & J
-
Figure Revenue and Market Share Analysis of J & J
-
Table Product and Service Introduction of J & J
-
